Research Article
Seroprevalence of Human Brucellosis among Syrian Refugees in Jordan, 2022
Table 3
The difference in reported symptoms (within 6 months of the date of data collection) between the Brucella IgG-positive and IgG-negative cohorts.
| Symptoms | IgG-positive (N = 149) | IgG-negative (N = 1411) | P value |
| Experienced any brucellosis symptoms | 9 (6.0%) | 40 (2.8%) | 0.045 | Undulant fever | 8 (5.4%) | 22 (1.6%) | 0.005 | Chills | 3 (2.0%) | 18 (1.3%) | 0.444 | Headache | 8 (5.4%) | 21 (1.5%) | 0.004 | Joint pain | 8 (5.4%) | 29 (2.1%) | 0.020 | Loss of appetite | 5 (3.4%) | 15 (1.1%) | 0.035 | Malaise | 2 (1.2%) | 17 (1.3%) | 0.702 | Myalgia | 3 (2.0%) | 19 (1.3%) | 0.511 | Back pain | 4 (2.7%) | 20 (1.4%) | 0.278 | Depression | 2 (1.3%) | 10 (0.7%) | 0.320 |
|
|